This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus vaccine significantly reduced the incidence of severe rotavirus gastroenteritis among African infants during the first year of life.

Author(s): Madhi SA, Cunliffe NA, Steele D, et al.

Published: 2010

Resource types: Peer-reviewed journal

Diseases: Rotavirus

Topics: Vaccine safety; Disease/vaccine specific information

Regions: Africa